Facebook
X
LinkedIn
ForwardFundamentals of Anticancer Therapy Day 3 - Enduring Material - Credit offering period - June 26, 2026 - December 31, 2026
Cell Cycle Non-Specific Anti-cancer Therapy
Heather Kennihan MSN, RN, OCN
Case Studies
Target Audience
Identify function of cell cycle non-specific anti-cancer therapy drugs
Explain the mechanism of action for anti-tumor antibiotics, alkylating agents, and nitrosoureas
Discuss side effects of each drug
Additional Information
| Attachment | Size |
|---|---|
 AHNB21-206 (2-26)_ACT book_final.pdf | 21.74 MB |
| AHNB21-207 (2-26) ACT SOP Manual 2026_final (1).pdf | 2.22 MB |
| AHNB21-208 (2-26) ACT Workbook Template_final.pdf | 3.62 MB |
Accreditation: Allegheny General Hospital is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Allegheny General Hospital designates this enduring material activity for a maximum of 2.25 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in this activity.
Allegheny Health Network is approved as a provider for nursing continuing professional development by Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation
Available Credit
- 2.25 AMA PRA Category 1 Credit™
- 2.25 Attendance
- 2.25 NCPD
AHN West Penn Hospital is approved as a provider of nursing continuing professional development by Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Nurses completing the entire activity and the evaluation tool will be awarded a maximum of 2.25 contact hours of nursing continuing professional development (NCPD).